# Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in Malaysia

> **NCT00539123** · NA · COMPLETED · sponsor: **Yale University** · enrollment: 234 (actual)

## Conditions studied

- Opiate Dependence

## Interventions

- **BEHAVIORAL:** behavioral drug and HIV risk reduction counseling (BDRC)
- **BEHAVIORAL:** abstinence-contingent buprenorphine (ACB)

## Key facts

- **NCT ID:** NCT00539123
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2011-08
- **Final completion:** 2012-08
- **Target enrollment:** 234 (ACTUAL)
- **Last updated:** 2021-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00539123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00539123, "Drug Counseling and Abstinent-Contingent Take-Home Buprenorphine in Malaysia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00539123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*